Christoph Samuel Ziegler insider trades
Open-market stock purchases and sales by Christoph Samuel Ziegler, Director at Veraxa Biotech AG - Post de-SPAC, from SEC Form 4 filings since Oct 20, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 20, 2026 | VRXA Veraxa Biotech AG - Post de-SPAC | Bought | $32.7K |
Companies traded
- VRXA Veraxa Biotech AG - Post de-SPAC: 1 buy, last Oct 20, 2026
Get free alerts when Christoph Samuel Ziegler files a new trade →